Dr. Deborah Kim, MD

Dr. Kim practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Dr. Kim's NPI, 1952723132, was assigned on January 7, 2014. Dr. Kim holds New Jersey license 25MA09545800.

Dr. Kim's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Dr. Kim also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Dr. Kim's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. Dr. Kim is also affiliated with Robert Wood Johnson University Hospital Somerset. The medical group on file is Rutgers-RWJ Scleroderma Program. Dmand AI also links Dr. Kim to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Kim's licenses on file in 2 states: New Jersey and Massachusetts.

CMS data shows 568 Medicare services from Dr. Kim across 11 procedure codes in 2024, for 260 Medicare patients. Medicare paid $56,440 for them.

CMS counts 260 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 68, with 54% women.

In 2024, Dr. Kim wrote 789 Medicare Part D claims for 114 patients. 45% of them were for generic drugs. CMS names the drug for 659 of them, across 18 drugs with 11 or more claims each, at $333,728 in total drug cost. In 2023, CMS named 818 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Kim for performance year 2024, reported through an alternative payment model (APM). Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 34 papers to Dr. Kim, published from 2003 to 2023. 2015 was the busiest year, with 4. The most frequent topics are Pregnancy Complications, Depressive Disorder, Major and Depressive Disorder. Dr. Kim has published most often in Curr Psychiatry Rep. Dr. Kim's most frequent co-authors are Cynthia Neill Epperson, MD, Michael E. Thase, MD and Pablo M. Tebas, MD.

Dmand AI links Dr. Kim to 2 clinical trials. Conditions studied include Depressive Disorder, Major, Stress, Psychological and Behavioral Symptoms. University of Pennsylvania sponsors the most, 2.

CMS Open Payments shows 1 general payment to Dr. Kim from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $12.